Skip to content

Assessment of Fatty Liver With Thermo-acoustic Device

Feasibility Study for Quantifying Fatty Liver Using Thermo-acoustic Imaging

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04302051
Enrollment
0
Registered
2020-03-10
Start date
2023-11-02
Completion date
2026-07-09
Last updated
2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatty Liver, Fatty Liver Disease, NAFLD, NASH, Non-alcoholic Fatty Liver, Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis

Brief summary

The study will evaluate the accuracy of hepatic steatosis estimation by thermo-acoustic ultrasound with estimation by MRI-PDFF (Proton Density Fat Fraction) . It will also evaluate the sensitivity of this device in the diagnosis of fatty liver.

Detailed description

Patients with either known or presumed diagnosis of non-alcoholic fatty liver disease who meets eligibility criteria will be included in the study. They will have imaging done to estimate hepatic steatosis by two modalities (MRI - PDFF and thermo-acoustic ultrasound). The estimation obtained by thermo-acoustic ultrasound will be compared with MRI results for accuracy of estimation by the thermo-acoustic ultrasound device. The study will also evaluate the sensitivity of the thermo-acoustic ultrasound device if it can diagnose the presence of hepatic steatosis when hepatic fat content is 15% or less by volume.

Interventions

DIAGNOSTIC_TESTThermo-acuostic image acquisition of liver

Estimation of hepatic fat content with thermo-acoustic device

DIAGNOSTIC_TESTMRI-PDFF estimation of hepatic fat

Estimation of hepatic fat content with MRI

Sponsors

Medical College of Wisconsin
Lead SponsorOTHER
ENDRA Life Sciences, Inc.
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* patients diagnosed or suspected to have non-alcoholic fatty liver disease * Patients 18-70 years of age * be able to understand and sign on written informed consent * able to undergo ultrasound and MRI examinations

Exclusion criteria

* any metal or electronic implants including but not limited to pacemakers, clips, hips * known history of pregnancy or becoming pregnant during study period * unable to understand and sign on written informed consent * intolerant to ultrasound and/or MRI examinations

Design outcomes

Primary

MeasureTime frameDescription
Correlation of hepatic fat estimation by the thermo-acoustic device with MRI-PDFF techniqueone yearThe study evaluates if the new thermo-acoustic device can accurately estimate the hepatic fat content among patients with non-alcoholic fatty liver disease to the currently approved method using MRI-PDFF scan.

Secondary

MeasureTime frameDescription
Evaluate the best and ideal number of the anatomical site for thermo-acoustic evaluation of liverOne yearThe study evaluates the number of estimation required and the appropriate anatomical site to evaluate the liver to obtain best results
Evaluate the sensitivity of the thermo-acoustic device in the diagnosis of hepatic steatosis.One yearEvaluate the sensitivity of the thermo-acoustic device in diagnosis presence of hepatic steatosis among patients with MRI-PDFF finding of more than 15% hepatic steatosis

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORACHUTHAN SOURIANARAYANANE, MD

Medical College of Wisconsin

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026